Executive Summary
Ark is a specialist healthcare group with operations in the UK and Finland. Ark focuses on areas of high unmet clinical need in vascular disease and cancer, where opportunities exist for effective new products to generate significant revenues. With one marketed product, three further products in late stage clinical development and an advanced pipeline of follow-on opportunities, Ark is becoming recognised for the strength of its portfolio and for the consistent progress it makes in its business operations.
Company History
Current Events
Business Model
Products/Services
Segments/Customers
Production/Operations
Distribution/Routes to Market
Market & Competition
Market Share
Main Competitors
Competitive Strengths and Weaknesses
Management
Financials
Profit & Loss
Balance sheet
Cashflow
Valuation
Comparable Companies
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
